1-20 of 44
Guoqing Wei
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of TP53 Allelic State on Outcomes of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Neoplasm

Bingqian Jiang, Tingting Yang, Yi Luo, Yanmin Zhao, Guifang Ouyang, Jian Yu, Jianping Lan, Ying Lu, Xiaoyu Lai, Baodong Ye, Yi Chen, Lizhen Liu, Yang Xu, Pengfei Shi, Haowen Xiao, Huixian Hu, Qunyi Guo, Huarui Fu, Yishan Ye, Xinyu Wang, Jie Sun, Weiyan Zheng, Jingsong He, Yi Zhao, Wenjun Wu, Zhen Cai, Guoqing Wei, He Huang, Jimin Shi
Journal: Blood
Blood (2023) 142 (Supplement 1): 2228.
https://doi.org/10.1182/blood-2023-184668
Published: 2023
Journal Articles

Long Term Follow-up Results of Brl-201 Phase I Study, a Crispr-Based Non-Viral PD-1 Locus Specific Integrated Anti-CD19 CAR-T Cells in Treating Relapsed or Refractory Non-Hodgkin's Lymphoma

Biao Zheng, Yongxian Hu, Jiqin Zhang, Mingming Zhang, Wei Li, Wenjun Wu, Jiazhen Cui, Guoqing Wei, Bing Du, Mingyao Liu, He Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 2108.
https://doi.org/10.1182/blood-2023-185573
Published: 2023
Journal Articles

A Multi-Omic Single-Cell Landscape of Cytokine Release Syndrome in Multiple Myeloma Patients after Anti-BCMA CAR-T Cell Therapy

Yongxian HU, Xia Li, Penglei Jiang, Tingting Yang, Tianning Gu, Xiaohui Si, Yali Xie, Mingming Zhang, Guoqing Wei, Huijun Xu, Zenan Cen, Jiazhen Cui, Simao Huang, Fang Ni, Linqin Wang, Xiujian Wang, Xiangjun Zeng, Delin Kong, Houli Zhao, Alex H. Chang, Yanlei Zhang, Jin Zhang, Jinyan Huang, Pengxu Qian, He Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 101.
https://doi.org/10.1182/blood-2023-185236
Published: 2023
Journal Articles

A Single Center Retrospective Study on the Efficacy of Haploidentical Hematopoietic Stem Cell Transplantation in Patients with Myeloid Neoplasms over 50 Years Old

Meng Liu, Xiaoli Wang, Yi Luo, Yanmin Zhao, Jian Yu, Xiaoyu Lai, Lizhen Liu, Huarui Fu, Weiyan Zheng, Jie Sun, Jingsong He, Yi Zhao, Guoqing Wei, Zhen Cai, He Huang, Jimin Shi
Journal: Blood
Blood (2023) 142 (Supplement 1): 7051.
https://doi.org/10.1182/blood-2023-184513
Published: 2023
Journal Articles

Hyperleukocytosis Does Not Present a Worse Prognosis in Acute Myeloid Leukemia (Non-APL) with Favorable Risk According to ELN-2022 Criteria: A Retrospective Study

Shuyue Bao, Jinya Lin, Yuanyuan Zhu, Weijia Huang, Weiyan Zheng, Guoqing Wei, Zhen Cai, Yi Luo, Yi Zhao, Jimin Shi, He Huang, Jie Sun
Journal: Blood
Blood (2023) 142 (Supplement 1): 5867.
https://doi.org/10.1182/blood-2023-186943
Published: 2023
Journal Articles

IPSS-M Predicts Survival Outcomes Significantly Better Than IPSS-R in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Neoplasms

Tingting Yang, Bingqian Jiang, Yi Luo, Yanmin Zhao, Guifang Ouyang, Jian Yu, Jianping Lan, Ying Lu, Xiaoyu Lai, Baodong Ye, Yi Chen, Lizhen Liu, Yang Xu, Qunyi Guo, Pengfei Shi, Haowen Xiao, Huixian Hu, Huarui Fu, Yishan Ye, Xinyu Wang, Jie Sun, Weiyan Zheng, Jingsong He, Yi Zhao, Wenjun Wu, Zhen Cai, Guoqing Wei, He Huang, Jimin Shi
Journal: Blood
Blood (2023) 142 (Supplement 1): 3579.
https://doi.org/10.1182/blood-2023-189068
Published: 2023
Journal Articles

Neither Conditioning Chemotherapy Nor GvHD-Prophylaxis: CD7 CAR-T Treatment Bridging to Haplo-HSCT

Yongxian Hu, Mingming Zhang, Tingting Yang, Ruirui Jing, Houli Zhao, Rongrong Chen, Tianning Gu, Pingnan Xiao, Ruimin Hong, Jingjing Feng, Shan Fu, Delin Kong, Huijun Xu, Jiazhen Cui, Simao Huang, Bin Liang, Guoqing Wei, Xiaolin Yuan, Qu Cui, Jiangtao Ren, Alex H. Chang, Dongrui Wang, He Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1039.
https://doi.org/10.1182/blood-2023-185697
Published: 2023
Journal Articles

Dasatinib and CAR-T Cell Therapy for Newly Diagnosed Ph-Positive Acute Lymphoblastic Leukemia in Adults

Mingming Zhang, Yongxian Hu, Guoqing Wei, Shan Fu, Jingjing Feng, Ruimin Hong, Alex H. Chang, He Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 891.
https://doi.org/10.1182/blood-2023-186225
Published: 2023
Journal Articles

Intracellular Retention of Tcrαβ/CD3 to Generate Novel Allogeneic CAR-T Cells (ThisCART19A) with Enhanced Antitumor Potency for Treating B-ALL

Yongxian HU, Guoqing Wei, Shan Fu, Pingnan Xiao, Jingjing Feng, Mingming Zhang, Xingbing Wang, Dongrui Wang, Jun Li, He Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 2111.
https://doi.org/10.1182/blood-2023-189052
Published: 2023
Journal Articles

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Myeloid Leukemia Harboring KMT2A Rearrangement and Its Prognostic Factors

Bingqian Jiang, Yanmin Zhao, Yi Luo, Jian Yu, Yi Chen, Baodong Ye, Huarui Fu, Xiaoyu Lai, Lizhen Liu, Yishan Ye, Weiyan Zheng, Jie Sun, Jingsong He, Yi Zhao, Guoqing Wei, Zhen Cai, He Huang, Jimin Shi
Journal: Blood
Blood (2023) 142 (Supplement 1): 2243.
https://doi.org/10.1182/blood-2023-182809
Published: 2023
Journal Articles

High Safety and Efficacy of CRISPR-Based Non-Viral PD-1 Locus Specific Integrated Anti-CD19 CAR-T Cells (BRL-201) in Treating Relapsed or Refractory Non-Hodgkin's Lymphoma: First-in-Human Phase I Study

Yongxian Hu, Jiqin Zhang, Mingming Zhang, Wei Li, Wenjun Wu, Jiazhen Cui, Guoqing Wei, Bing Du, Mingyao Liu, He Huang
Journal: Blood
Blood (2022) 140 (Supplement 1): 7491–7492.
https://doi.org/10.1182/blood-2022-156137
Published: 2022
Journal Articles

Safety and Efficacy of CD19 CAR-T Cells for Refractory Systemic Sclerosis: A Phase I Clinical Trial

Jingjing Feng, Yongxian Hu, Mingming Zhang, Heng Cao, Yini Ke, Huijun Xu, Jiazhen Cui, Yanlei Zhang, Alex Hongsheng Chang, Jin Lin, Guoqing Wei, He Huang
Journal: Blood
Blood (2022) 140 (Supplement 1): 10335–10336.
https://doi.org/10.1182/blood-2022-169265
Published: 2022
Journal Articles

Predictive Value of Next-Generation Sequencing-Based Minimal Residual Disease after CAR-T Cell Therapy

Yue Huang, Houli Zhao, Mi Shao, Linghui Zhou, Guoqing Wei, Wenjun Wu, Alex Hong Chang, Tao Sun, Yongxian HU, He Huang
Journal: Blood
Blood (2021) 138 (Supplement 1): 2842.
https://doi.org/10.1182/blood-2021-149928
Published: 2021
Journal Articles

The Safety and Efficacy of a CRISPR/Cas9-Engineered Universal CAR-T Cell Product (CTA101) in Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Yongxian Hu, MD, Yali Zhou, Mingming Zhang, MD, Wengang Ge, Yi Li, MD, Li Yang, MD, Guoqing Wei, MD, Lu Han, Hao Wang, Xingwang Zhang, PhD, Jiangtao Ren, PhD, He Huang, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 52.
https://doi.org/10.1182/blood-2020-142262
Published: 2020
Journal Articles

Clinical Characterization and Risk Factors Associated with Cytokine Release Syndrome Induced By COVID-19 and Chimeric Antigen Receptor T-Cell Therapy

Ruimin Hong, Houli Zhao, MD, Yiyun Wang, Yu Chen, Hongliu Cai, Yongxian Hu, MD, Guoqing Wei, MD, He Huang, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 35–36.
https://doi.org/10.1182/blood-2020-139007
Published: 2020
Journal Articles

Potent Anti-Tumor Activity of Bcma CAR-T Therapy Against Heavily Treated Multiple Myeloma and Dynamics of Immune Cell Subsets Using Single-Cell Mass Cytometry

Yongxian Hu, MD, Zhang Yanlei, Guoqing Wei, Chang alex Hong, He Huang
Journal: Blood
Blood (2019) 134 (Supplement_1): 1859.
https://doi.org/10.1182/blood-2019-130341
Published: 2019
Journal Articles

Maintenance Sorafenib Is Superior to Prophylactic DLI in Improving the Prognosis of FLT3-ITD-Positive AML after Allogeneic HSCT

Jimin Shi, MD, Liqin Cao, MD, Yi Luo, MD, Yanmin Zhao, MD, Yamin Tan, MD, Jian Yu, MD, Xiaoyu Lai, MD, Yuanyuan Zhu, MD, Yongxian Hu, MD, Jingsong He, MD, Jie Sun, MD, Weiyan Zheng, MD, Guoqing Wei, MD, He Huang
Journal: Blood
Blood (2019) 134 (Supplement_1): 2668.
https://doi.org/10.1182/blood-2019-127594
Published: 2019
Journal Articles

The Effect of Continuous Screening of Carbapenem-Resistant Enterobacteriaceae on Theprevention and Control of Bloodstream Infections in Patients with Hematopoietic Stemcell Transplantation

Tingting Yang, Xueping Luo, MD, Qing Yang, MD, Hongchao Chen, Yi Luo, MD, Yanmin Zhao, MD, Xiaoyu Lai, MD, Jian Yu, MD, Yamin Tan, MD, Guoqing Wei, MD, He Huang, Jimin Shi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5606.
https://doi.org/10.1182/blood-2019-127599
Published: 2019
Journal Articles

Comparison of Chimeric Antigen Receptor T Cells from Allogenic or Autologous Sources in Patients with Acute Lymphoblastic Leukemia

Yongxian Hu, MD PhD, Jiasheng Wang, MD, Yanlei Zhang, Guoqing Wei, MD, Huijun Xu, Wenjun Wu, MD, Jian Yu, MD, Yi Luo, MD, Jimin Shi, MD, Shaohui Liu, Kangyan Wang, Zhenxing Guo, Alex HONGSHENG Chang, He Huang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2691.
https://doi.org/10.1182/blood-2018-99-117910
Published: 2018
Journal Articles

Chimeric Antigen Receptor T-Cell Therapy Shapes T Cell Repertoire in Chinese Patients with B-Cell Acute Lymphocyte Leukemia

Xiujian Wang, Tao Sun, PhD, Yongxian Hu, MD PhD, Xiao Liu, PhD, Jian Yu, MD, Pengfei Xu, Guoqing Wei, MD, Chao Jin, Wenjun Wu, MD, Fu Huarui, MD, Lijuan Ding, Fang Ni, Hao Zhang, Zuyu Liang, Binsheng Wang, PhD, Xiaoqing Li, Cong Wei, Yunyun Deng, MS, Jimin Shi, MD, Lei Xiao, PhD, Zhao Wu, PhD, He Huang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1413.
https://doi.org/10.1182/blood-2018-99-115780
Published: 2018